The pursuit of an effective staphylococcal vaccine has never been more critical, as
community-associated MRSA has become the most common bacterial infection in the US. In …

Staphylococcus aureus infections, particularly those that are methicillin-resistant (MRSA),
continue to plague patients and clinicians alike. The prevalence of MRSA is a global …

High attack rates and the ability of Staphylococcus aureus to develop resistance to all
antibiotics in medical practice heightens the urgency for vaccine development. S. aureus …

Developing a universal vaccine for S. aureus is a top priority but to date we have only had
failures in human clinical trials. Given the plethora of bacterial virulence factors, broad range …

Development of an effective vaccine against Staphylococcus aureus would provide great
potential public health benefit. We present a brief overview of the current knowledge in this …

Bacterial vaccines have made dramatic impacts upon morbidity and mortality caused by a
number of common pathogens, but a vaccine to prevent Staphylococcus aureus infections …

Vaccine Efficacy (STRIVE) trial is another disappointment. However, the information
provided by Hassanzadeh et al is extremely valuable as it can instruct future clinical trials …

Staphylococcus aureus, a prevalent human pathogen and a leading cause of hospital-
acquired infections, is increasingly evolving antibiotic-resistant strains, increasing mortality …

In this review, we examine the current status of S taphylococcus aureus vaccine
development and the prospects for future vaccines. Examination of the clinical trials to date …

Staphylococcus aureus is a fastidious pathogen of global concern. S. aureus can not only
cause a wide range of serious infections, but can also colonize healthy individuals …